Matches in Nanopublications for { ?s ?p "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293456.RATCKx5v2BztIk1mdbLrOViTep2-V_IYYqhi_3ZHTOIKU130_assertion description "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293456.RATCKx5v2BztIk1mdbLrOViTep2-V_IYYqhi_3ZHTOIKU130_provenance.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion description "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.